TLC BioSciences
Edit

TLC BioSciences

http://www.tlcbio.com/
Tags:DeliveryDevelopmentDrugLifeManagementMedtechProduct
At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy. We focus on creating new therapies in the areas of pain management, oncology, ophthalmology and infectious diseases. Effective drug development is a challenging and complex effort that requires the coordinated talents of many skilled individuals working as a team. If you believe in the potential for new medicines to improve quality of life and bring hope to those in need, we invite you to join us. We welcome applications from all over the globe.
Location: Taiwan, Taipei
Member count: 51-200
Total raised: $23M
Founded date: 1997

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
30.06.2020-$23M--

Mentions in press and media 14

DateTitleDescriptionCategoryAuthorSource
26.08.2021Taiwan Lip...Taiwan Liposome Company, Ltd. ...--marketscre...
12.08.2021Taiwan Lip...TLC Reports Second Quarter 202...--marketscre...
12.08.2021TLC Report...SOUTH SAN FRANCISCO, Calif. an...--marketscre...
25.05.2021TAIWAN LIP...TLC Announces Approval of New ...--marketscre...
03.05.2021TAIWAN LIP...TLC Earns Highest Ranking in C...--marketscre...
22.02.2021Taiwan Lip...TAIWAN LIPOSOME COMPANY, LTD. ...--marketscre...
22.02.2021TAIWAN LIP...TAIWAN LIPOSOME COMPANY, LTD. ...--marketscre...
22.02.2021TAIWAN LIP...TAIWAN LIPOSOME COMPANY, LTD. ...--marketscre...
22.02.2021Taiwan Lip...TAIWAN LIPOSOME COMPANY, LTD. ...--marketscre...
03.11.2020TAIWAN LIP...TAIWAN LIPOSOME COMPANY, LTD. ...--marketscre...
Show more